About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Chicago | 383 Studies

Clinical Trials Prostate CancerChicago

Prostate Cancer Clinical Trials in Chicago

Find 383 clinical trials for prostate cancer near Chicago, Illinois. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 383 trials

RecruitingA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesThis is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx)…NCT06395519·Phoenix, Arizona and 13 others CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedDecreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.Doctors leading this study plan to collect new information about the lowest effective dose of abiraterone acetate in study participants with prostate cancer who are taking…NCT05276492·Chicago, Illinois

RecruitingSafety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsA Phase 1 Open-Label, First-in-human, Dose Escalation and Expansion Study to Determine the Safety, Tolerability, Dosimetry, Pharmacokinetics, and Preliminary Efficacy of…NCT05283330·Chicago, Illinois and 7 others

TerminatedDocetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerThis randomized phase II trial studies how well docetaxel and prednisone with or without vaccine therapy works in treating patients with hormone-resistant prostate cancer that has…NCT01145508·Jacksonville, Florida and 13 others

CompletedDose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPCThe combination treatment of protein kinase B (AKT) inhibitor, afuresertib, with androgen synthesis enzyme inhibitor, LAE001, may provide an effective treatment for metastatic…NCT04060394·Tucson, Arizona and 16 others

CompletedStockholm3 Validation Study in a Multi-Ethnic CohortIntroduction: Prostate cancer (PCa) is the most commonly detected cancer in men and is the second leading cause of cancer death.NCT04583072·Los Angeles, California and 13 others

CompletedLycopene in Healthy Male ParticipantsThis randomized phase I trial is studying the side effects and best dose of lycopene in healthy male participants.NCT00450957·Chicago, Illinois

CompletedRadiation Therapy in Treating Patients With Stage II Prostate CancerRATIONALE: Giving radiation therapy that uses a 3-dimensional (3-D) image of the tumor to help focus thin beams of radiation directly on the tumor, and giving hypofractionated…NCT00331773·Phoenix, Arizona and 295 others

CompletedA Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerThe purpose of this study is to determine the benefit of enzalutamide versus placebo as assessed by overall survival and progression-free survival in patients with progressive…NCT01212991·Birmingham, Alabama and 268 others

RecruitingFK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate CancerThe goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remove their prostate…NCT06636682·Chicago, Illinois and 2 others

CompletedRandomized Salvage Radiation Therapy Plus Enzalutamide Post ProstatectomyThe primary hypothesis of this study is that outcomes for patients with biochemically recurrent prostate cancer following radical prostatectomy will be improved by the addition of…NCT02203695·Washington D.C., District of Columbia and 8 others

CompletedProstate Cancer Intervention Versus Observation Trial (PIVOT)Radical prostatectomy provides potentially curative removal of the cancer.NCT00007644·Birmingham, Alabama and 30 others

CompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerRandomized phase III trial to compare the effectiveness of low, intermediate, and high dose suramin in treating men with stage IV prostate cancer that is refractory to hormone…NCT00002723·Chicago, Illinois and 26 others

TerminatedTroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)Based on both pre-clinical and clinical data, it may be advantageous to administer a cancer vaccine before chemotherapy to enhance immune responses, thus leading to a more…NCT01194960·San Bernardino, California and 6 others

RecruitingUsing MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of LifeThe purpose of this research is to gather information on the safety and effectiveness of using an imaging technique called magnetic resonance imaging (MRI) to decrease radiation…NCT06171269·Chicago, Illinois

Active not recruitingA Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyThis randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men…NCT04455750·Anchorage, Alaska and 413 others

CompletedVaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Vaccines made from a patient's white blood cells may make the body build an immune response to kill cancer cells.NCT00015977·Chicago, Illinois

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

UnknownLycopene in Preventing Prostate Cancer in Healthy ParticipantsRATIONALE: Chemoprevention is the use of certain drugs or substances to keep cancer from forming, growing, or coming back.NCT00322114·Chicago, Illinois

PreviousPage 15 of 20Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma